Microbiome Sequencing Service Market Report 2026

The microbiome sequencing service market size has grown rapidly in recent years. It will grow from $2.43 billion in 2025 to $2.84 billion in 2026 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to expansion of microbiome research initiatives, increasing academic research funding, rising interest in gut and skin microbiota studies, availability of next-generation sequencing platforms, growing collaboration between academia and industry.

The microbiome sequencing service market size is expected to see rapid growth in the next few years. It will grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing clinical adoption of microbiome-based diagnostics, rising investments in microbiome therapeutics, expansion of personalized nutrition research, growing use of ai-driven microbial analysis, increasing demand for large-scale population microbiome studies. Major trends in the forecast period include increasing demand for high-throughput microbiome sequencing services, growing use of shotgun and amplicon sequencing, rising integration of advanced bioinformatics pipelines, expansion of clinical microbiome research applications, enhanced focus on functional microbial profiling.

The rising incidence of gut-related diseases is expected to propel the growth of the microbiome sequencing service market going forward. Gut-related diseases affect the gastrointestinal tract and are increasing due to lifestyle and dietary changes. Microbiome sequencing services support disease management by analyzing gut microbial composition and guiding targeted interventions. For instance, in June 2025, laboratory reports for Campylobacter infections in the UK increased by 27% between 2022 and 2024. Therefore, the rising incidence of gut-related diseases is driving the growth of the microbiome sequencing service market.

Leading companies operating in the microbiome sequencing service market are focusing on developing advanced solutions, such as automated metagenomics sequencing solutions, to enhance efficiency, accuracy, and scalability in microbiome research and analysis. An automated metagenomics sequencing solution is a comprehensive system that enables sequencing and analysis of microbial communities with minimal manual intervention, ensuring high accuracy, reproducibility, and scalable throughput. For instance, in July 2024, MGI Tech Co. Ltd., a China-based biotechnology company, launched the Human Microbiome Metagenomics Sequencing Package. The product delivers a fully integrated workflow that combines automated sample pretreatment, nucleic acid extraction, library preparation, sequencing, and data analysis to support high-throughput and cost-efficient microbiome research. Its validated performance across a large number of human stool samples ensures reproducibility and accuracy, establishing a benchmark for large-scale human microbiome studies.

In May 2025, Mapmygenome India Limited, an India-based genomics and diagnostics company, acquired Microbiome Insights Inc. for an undisclosed amount. Through this acquisition, Mapmygenome aims to enhance microbiome sequencing and analytical capabilities, strengthen its footprint in North America, and expand its genomics and personalized health services. Microbiome Insights Inc. is a Canada-based biotechnology company specializing in microbiome sequencing services.

Major companies operating in the microbiome sequencing service market are Eurofins Scientific LLC, Illumina Inc., Charles River Laboratories, QIAGEN N.V., Mérieux NutriSciences Corporation, OraSure Technologies Inc., Zifo RnD Solutions, Novogene Co. Ltd., Oxford Nanopore Technologies Plc, Macrogen Inc., Zymo Research Corporation, CD Genomics, Molzym GmbH & Co. KG (Gradian Diagnostics), Baseclear BV, Psomagen Inc., Mapmygenome, Rancho Biosciences LLC, Boster Biological Technology Ltd., Clinical Microbiomics, Microba Life Sciences Limited.

North America was the largest region in the microbiome sequencing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbiome sequencing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbiome sequencing service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the microbiome sequencing service market by increasing costs of imported sequencing instruments, reagents, consumables, and computational infrastructure. Pharmaceutical companies, academic institutes, and biotech firms in North America and Europe are most affected due to reliance on imported sequencing platforms, while Asia-Pacific faces higher service delivery costs. These tariffs are increasing per-sample sequencing prices and extending research timelines. At the same time, they are encouraging regional sequencing hubs, localized reagent sourcing, and investment in cost-efficient service models that enhance long-term market sustainability.

The microbiome sequencing service market research report is one of a series of new reports that provides microbiome sequencing service market statistics, including microbiome sequencing service industry global market size, regional shares, competitors with a microbiome sequencing service market share, detailed microbiome sequencing service market segments, market trends and opportunities, and any further data you may need to thrive in the microbiome sequencing service industry. This microbiome sequencing service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A microbiome sequencing service is a scientific offering that examines the genetic material of microbial populations found in samples such as the gut, skin, or environmental sources. It is used to identify, quantify, and characterize microorganisms to assess their composition, diversity, and potential functional roles.

The primary services of microbiome sequencing service include sample preparation, sequencing and library preparation, and data analysis. Sample preparation involves processing biological samples to ensure sufficient quality and purity for sequencing. Technologies used include sequencing by ligation (SBL), sequencing by synthesis (SBS), shotgun sequencing, targeted gene sequencing, RNA sequencing, and others. Applications include autoimmune disorders, cancer, gastrointestinal diseases, and others, serving end-users such as pharmaceutical and biotechnology companies, academic research institutes, and others.

The microbiome sequencing service market includes revenues earned by entities through microbiome biomarker discovery, host-microbiome interaction analysis, microbial strain identification, metatranscriptomic profiling, metaproteomic analysis, metabolomic profiling, microbiome-based diagnostics development, and microbiome therapeutics support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.